Related Experiment Video
Updated: Jul 20, 2025
10:11
Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
23.2K
p16 Immunohistochemical Expression in Nephrogenic Adenoma.
Juan Carlos Alvarez Moreno1, Hafiz A Ghani1, Vasily Ovechko1
1Pathology, University of Texas Medical Branch at Galveston, Galveston, USA.
Cureus
|August 3, 2023
Summary
Nephrogenic adenoma (NA), a rare bladder condition, was studied for p16 expression. Researchers found p16 can be a valuable diagnostic marker for this entity.
Area of Science:
- Uropathology
- Oncologic diagnostics
Background:
- Nephrogenic adenoma (NA) is a rare metaplastic lesion.
- It typically arises after urothelial injury, commonly in the bladder or urethra.
Purpose of the Study:
- To evaluate p16 expression as a potential diagnostic marker for nephrogenic adenoma.
- To correlate p16 expression with clinicopathological parameters in NA cases.
Main Methods:
- Retrospective analysis of 17 nephrogenic adenoma cases.
- Immunohistochemical assessment of p16 expression.
Main Results:
- p16 expression was evaluated in the studied NA cases.
- Correlation with clinical and pathological data was performed.
Conclusions:
- p16 immunohistochemistry shows potential as a diagnostic tool for nephrogenic adenoma.
- Further studies may confirm its utility in differentiating NA from other urothelial lesions.
